Clinicians should be aware of the possibility of false positive troponin levels, especially when the results are not consistent with clinical presentation of the patient.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Although cardiac troponins play a central role in the diagnosis and risk stratification of patients with acute coronary syndrome and are frequently used to determine whether a patient with chest pain has had cardiac damage, a false positive value can result in unnecessary hospitalization and enrollment of potentially invasive tests.
📊
Key Findings & Data:Although cardiac troponins play a central role in the diagnosis and risk stratification of patients with acute coronary syndrome and are frequently used to determine whether a patient with chest pain has had cardiac damage, a false positive value can result in unnecessary hospitalization and enrollment of potentially invasive tests.
💡
Conclusion & Impact:Clinicians should be aware of the possibility of false positive troponin levels, especially when the results are not consistent with clinical presentation of the patient.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Although cardiac troponins play a central role in the diagnosis and risk stratification of patients with acute coronary syndrome and are frequently used to determine whether a patient with chest pain has had cardiac damage, a false positive value can result in unnecessary hospitalization and enrollment of potentially invasive tests. Clinicians should be aware of the possibility of false positive troponin levels, especially when the results are not consistent with clinical presentation of the patient.
Özet
Kardiyak troponinler akut koroner sendromların tanı ve risk sınıflamasında merkezi bir rol oynayıp göğüs ağrısının nedeninin kardiyak hasara bağlı olup olmadığının belirlenmesinde kullanılsa da yanlış pozitif sonuçlar hastaların gereksiz hospitalize edilmesine ve invazif işlemlerin uygulanmasına yol açabilir. Klinisyenler hastaların klinik özellikleri troponin seviyeleri ile korelasyon göstermediği durumlarda, troponin yüksekliğinin yanlış pozitif olabileceği ihtimalini göz önünde bulundurmalıdır.
Coudrey L. The troponin. Arch Intern Med 1998;158:1173-80
Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patientspresenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999- 3054. doi: 10.1093/eurheartj/ehr236. Epub 2011 Aug 26
Antman EM. Decision making with cardiac troponin tests (editorial). N Engl J Med 2002;346:2079-82
Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease:the present and the future. J Am Coll Cardiol 2006;48:1- 11. Epub 2006 Jun 12
De Gennaro L, Brunetti ND, Cuculo A, et al. Increased troponin levels in non-ischemic cardiac conditions and non-cardiac diseases. J Interv Cardiol 2008;21:129-39. Epub 2008 Jan 28
Kenny PR, Finger DR. Falsely elevated cardiac troponin-I in patients with seropositive rheumatoid arthritis. J Rheumatol 2005;32:1258-61
Calogiuri GF, Nettis E, Di Leo E, Vacca A, Ferrannini A, Kounis NG. Kounis Syndrome induced by intravenous administration of piperacillin/tazobactam: a case report. Int J Cardiol 2012;155:e42-4. Epub 2011 Aug 11.